Evaluation of Drug Interactions in Polypharmacy: A Case Study of Patients with Heart Failure Hospitalized at Tangerang District Hospital

Sondang Khairani; Reise Reise Manninda Manninda; Lusiana Ariani

doi:10.24071/jpsc.0010033

Evaluation of Drug Interactions in Polypharmacy: A Case Study of Patients with Heart Failure Hospitalized at Tangerang District Hospital

Sondang Khairani^(1*), Reise Reise Manninda Manninda⁽²⁾, Lusiana Ariani⁽³⁾,

(1) Universitas Pancasila
(2)
(3)
(*) Corresponding Author

Abstract

Heart failure is a condition in which the heart is unable to pump enough blood to meet the body's metabolic needs. It is a clinical syndrome with signs and symptoms caused by abnormalities in the structure and/or function of the heart. Heart failure occurs when the heart can't pump enough blood to meet the body's needs. It is caused by problems with the structure or function of the heart. This can lead to polypharmacy, where several medications are often taken by patients with heart failure to manage their condition. This study aims to identify patient characteristics, treatment accuracy based on Indonesian Heart Association (PERKI) 2023 guidelines, and the relationship between drug interactions and polypharmacy in adult patients diagnosed with heart failure with or without comorbidities at Tangerang Regency Hospital in 2023. The research was conducted descriptively using a cross-sectional study design. A total of 78 samples specimens met the inclusion criteria, with a male majority of 37 (52.86%) patients. The most common age group was 56-65 years old with 25 (35.71%) patients. The most common length of stay was 1-5 days with 48 (68.57%) patients. Evaluation of the treatment accuracy showed that the appropriate drug class was achieved in 78 (100%) patients, the appropriate dose in 55 (70.51%) patients and the appropriate frequency in 45 (57.69%) patients. Statistical tests showed a correlation between polypharmacy and drug-drug interactions with p-value <0.05. Accordingly, it is important to enhance monitoring and assessment of drug interactions in heart failure patients to optimize treatment management and prevent the risk of complications

Keywords

Drug Interactions; Heart failure; Polypharmacy

Full Text:

PDF

References

Adondis, J., Mongi, J., Tiwow, G., and Palandi, R.R., 2019. Study of potential drug interactions in heart failure patients at the inpatient installation of Adventist Hospital Manado. The Tropical Journal of Biopharmaceutical, 2(2), 124–135.

Alhumaidi, R.M., Bamagous, G.A., Alsanosi, S.M., Alqashqari, H.S., Qadhi, R.S., Alhindi, Y.Z., Ayoub, N., Falemban, A.H., 2023. Risk of polypharmacy and its outcome in terms of drug interaction in an elderly oopulation: A retrospective cross-sectional study. Journal of Clinical Medicine, 12.

Amelia, R., Adiputro, D.L., Biworo, A., Rudiansyah, M. Illiandri, O., 2023. Incidence of heart failure patients with comorbid hypertension at SUD Ulin Banjarmasin. Homeostasis, 5(3), 679.

Boyette, L.C., and Manna, B., 2023. Physiology, Myocardial Oxygen Demand. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK499897/

Cowie, M.R., Anker, S.D., Cleland, J.G.F., Felker, G.M., Filippatos, G., Jaarsma, T., Jourdain, P., Knight, E., Massie, B., Ponikowski, P., López-Sendón, J., 2014. Improving care for patients with acute heart failure: before, during and after hospitalization. ESC Heart Failure, 1(2), 110–145.

Fadilah, H., Indria, D.M., Wibisono, N., 2023. The relationship between polypharmacy and potential drug interactions in patients prescribed antihyperlipidemia drugs. Jurnal Bio Komplementer Medicine, 10(1).

Ferdinand, E., and Widyantari, N.M.C., 2023. Management of pediatric heart failure. Cermin Dunia Kedokteran, 50(3), 126–132.

Hamzah, R., Widaryati, W., 2017. The relationship between age and gender with quality of life in patients with heart failure at PKU Muhammadiyah Yogyakarta Hospital.

Imaligy, E.U., 2014. Heart ailure in geriatrics. Cermin Dunia Kedokteran, 41(1), 19–24.

Jain, S., Jain, P., Sharma, K., Saraswat, P., 2017. A prospective analysis of drug interactions in patients of intensive cardiac care unit. Journal of Clinical and Diagnostic Research, 11(3), FC01–FC04.

Ministry of Health Indonesia, 2018. Basic Health Research 2018. Jakarta

Khairani, S., Ramadaniati, H.U., Sarnianto, P., 2023. Evaluation of antibiotic use with quantitative methods in hospitalization pneumonia patients at West Nusa Tenggara Hospital (Evaluasi penggunaan antibiotik dengan metode kuantitatif pada pasien pneumonia rawat INAP di Rumah Sakit Nusa Tenggara Barat. Indonesian Journal of Pharmaceutical Sciences. 21(2), 300–307.

Mathers, C., Stevens, G., Hogan, D., Mahanani, W.R., Ho, J., 2017. Global and Regional Causes of Death: Patterns and Trends, 2000–15. In Disease Control Priorities, Third Edition (Volume 9): Improving Health and Reducing Poverty (pp. 69–104). The World Bank.

Ningrum, W.A., Febriyani, W., Muthoharoh, A., 2022. Effectiveness of treatment therapy based on age and duration of congestive heart failure (CHF) patients at Kajen Hospital, Pekalongan Regency. The 16th University Research Colloqium 2022 Universitas Muhammadiyah Pekajangan Pekalongan Pekajangan Pekalongan, 1765–1772.

Nurkhalis, Adista, R. J., 2020. Clinical manifestations and management of heart failure. Jurnal Kedokteran Nanggroe Medika, 3(3), 104–115.

Palleria, C., Di Paolo, A., Giofrè, C., Caglioti, C., Leuzzi, G., Siniscalchi, A., De Sarro, G., Gallelli, L., 2013. Pharmacokinetic drug-drug interaction and their implication in clinical management. Journal of Research in Medical Sciences, 18(7), 600–609.

Praha, S.D., Fauzi, L.,2021. Mortality risk of congestive heart failure (CHF) patients: A hospital-based retrospective cohort study. Indonesian Journal of Public Health and Nutrition, 1(3), 388–395.

Puspitasari, A. W., Angeline, L., 2019. Analisis potensi interaksi obat golongan antidepresan pada pasien skizofrenia di rumah sakit jiwa Dr. Soeharto Heerdjan tahun 2016 [Analysis of potential antidepressant drug interactions in schizophrenic patients at Dr. Soeharto Heerdjan 2016]. Pharmaceutical Sciences and Research, 6(1), 13–20.

Rojas-Ocaña, M.J., Teresa-Morales, C., Ramos-Pichardo, J.D., Araujo-Hernández, M., 2023. Barriers and facilitators of communication in the medication reconciliation process during hospital discharge: Primary healthcare professionals’ perspectives. Healthcare (Switzerland), 11(10).

Sapna, F., Raveena, F., Chandio, M., Bai, K., Sayyar, M., Varrassi, G., Khatri, M., Kumar, S., Mohamad, T., 2023. Advancements in heart failure management: A comprehensive narrative review of emerging therapies. Cureus, 15(10), 1–13.

Saputri, M., Dewi, S. R., 2023. Potential polypharmacy interactions of coronary heart disease (CHD) patients at I.A. Moeis Samarinda Hospital. Jurnal Sains Dan Kesehatan, 5(2), 109–114.

Sheikh-Taha, M., Asmar, M., 2021. Polypharmacy and severe potential drug-drug interactions among older adults with cardiovascular disease in the United States. BMC Geriatrics, 21(233), 2–6.

Sulistiyowatinngsih E, Nurul H, Febrianti., 2016. View of potential study of drug interactions in heart failure patients with renal function disturbance at the inpatient of Dr. Sardjito Yogyakarta hospital period 2009-2013. Jurnal Ilmiah Farmasi, 12(1), 35–43.

Triposkiadis, F., Xanthopoulos, A., Butler, J., 2019. Cardiovascular aging and heart failure. Journal Of the American College Of Cardiology, 74(6), 1–10.

Utami, F., 2022. Overview of personal characteristics in heart failure patients: A narrative review article. Jurnal Ilmiah Keperawatan Indonesia (JIKI), 5(1), 45–57.

Wulandari, T., Hadari Nawawi, J. H., 2018. Description of drug use in patients with congestive heart failure hospitalized in Sultan Syarif Mohamad Alkadrie Pontianak Hospital. Jurnal Mahasiswa Farmasi Fakultas Kedokteran UNTAN, 3(1).

DOI: https://doi.org/10.24071/jpsc.0010033